However, this association did not reach statistical significance as a risk factor for PFS ( Figure 5 a).
← all excerpts
<i>RYK</i> Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients.
1
—
—